I dont get how outlook for nvo is so bad, they codominate the weight loss drug market, innovate with new drugs. Gonna be 20% over estimates at least.




Yes, plus I have some cash available. I'm considering doubling my position after the results and an analysis of them.



Let's see if these results and the price agreement with the White House give the stock a little boost.